Related Experiment Videos

Trimethoprim resistance in Haemophilus influenzae is due to altered dihydrofolate reductase(s)

R de Groot1, D O Chaffin, M Kuehn

  • 1Division of Infectious Disease, Children's Hospital and Medical Center, Seattle, WA.

Insights

Trimethoprim resistance in Haemophilus influenzae is linked to altered dihydrofolate reductase (DHFR) enzymes. These resistant strains overproduce structurally different DHFR, impacting drug efficacy.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Dihydrofolate reductase (DHFR) is a crucial enzyme in folate metabolism.
  • Trimethoprim is an antibiotic that targets DHFR.
  • Antibiotic resistance is a growing public health concern.

Purpose of the Study:

  • To characterize the chromosomally encoded dihydrofolate reductase (DHFR) from trimethoprim-susceptible and resistant strains of Haemophilus influenzae.
  • To investigate the molecular basis of trimethoprim resistance in H. influenzae.

Main Methods:

  • Enzyme purification using gel-filtration and dye-ligand chromatography.
  • Enzyme activity assays, including Km determination and IC50 measurements for trimethoprim and methotrexate.
  • Isoelectric focusing and peptide mapping to analyze enzyme structure.

Main Results:

  • Purified DHFR from trimethoprim-resistant strains showed higher total enzyme activity.
  • Resistant DHFR enzymes exhibited significantly higher IC50 values for trimethoprim compared to susceptible strains.
  • Structural differences were observed in DHFR from resistant strains, including altered isoelectric points and tryptic peptide profiles.

Conclusions:

  • Trimethoprim resistance in H. influenzae is associated with overproduction of structurally altered DHFR.
  • These structural alterations likely contribute to reduced drug binding and confer resistance.
  • Understanding these mechanisms is vital for developing strategies to combat antibiotic resistance.

Related Concept Videos